183 related articles for article (PubMed ID: 31451680)
1. Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
Zhang H; Shen T; Zhang Z; Li Y; Pan Z
Med Sci Monit; 2019 Aug; 25():6418-6428. PubMed ID: 31451680
[TBL] [Abstract][Full Text] [Related]
2. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
4. KIF18A knockdown reduces proliferation, migration, invasion and enhances radiosensitivity of esophageal cancer.
Qian LX; Cao X; Du MY; Ma CX; Zhu HM; Peng Y; Hu XY; He X; Yin L
Biochem Biophys Res Commun; 2021 Jun; 557():192-198. PubMed ID: 33872988
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
6. High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Zhang Z; Xie H; Zhu S; Chen X; Yu J; Shen T; Li X; Shang Z; Niu Y
Med Sci Monit; 2018 Nov; 24():8190-8197. PubMed ID: 30427826
[TBL] [Abstract][Full Text] [Related]
7. The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
Luo W; Liao M; Liao Y; Chen X; Huang C; Fan J; Liao W
World J Surg Oncol; 2018 Feb; 16(1):36. PubMed ID: 29466986
[TBL] [Abstract][Full Text] [Related]
8. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
12. ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.
Shimizu K; Matsumoto H; Hirata H; Ueno K; Samoto M; Mori J; Fujii N; Kawai Y; Inoue R; Yamamoto Y; Yano S; Shimabukuro T; Furutani-Seiki M; Matsuyama H
Oncol Rep; 2020 Dec; 44(6):2735-2745. PubMed ID: 33125156
[TBL] [Abstract][Full Text] [Related]
13. Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo.
Chen FT; Zhong FK
Dis Markers; 2019; 2019():6383685. PubMed ID: 31772692
[TBL] [Abstract][Full Text] [Related]
14. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
[TBL] [Abstract][Full Text] [Related]
16. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
17. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
Chen W; Liu Y; Chen H; Ning H; Ding K
Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
Cui F; Hu J; Ning S; Tan J; Tang H
Prostate; 2018 Dec; 78(16):1299-1310. PubMed ID: 30095171
[TBL] [Abstract][Full Text] [Related]
19. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
Yang N; Wang L; Chen X; Liu J; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
[TBL] [Abstract][Full Text] [Related]
20. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]